Cargando…
(68)Ga-DOTATATE PET/CT and MRI with Diffusion-Weighted Imaging (DWI) in Short- and Long-Term Assessment of Tumor Response of Neuroendocrine Liver Metastases (NELM) Following Transarterial Radioembolization (TARE)
SIMPLE SUMMARY: TARE with (90)Yttrium has become a valuable treatment option for patients with unresectable NELMs. However, early evaluation of therapy response remains challenging as size-based response assessments (such as RECIST) are known to be limited, especially in slow-growing tumors. Alterna...
Autores principales: | Ingenerf, Maria, Kiesl, Sophia, Karim, Salma, Beyer, Leonie, Ilhan, Harun, Rübenthaler, Johannes, Seidensticker, Max, Ricke, Jens, Schmid-Tannwald, Christine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8431353/ https://www.ncbi.nlm.nih.gov/pubmed/34503131 http://dx.doi.org/10.3390/cancers13174321 |
Ejemplares similares
-
Apparent diffusion coefficients (ADC) in response assessment of
transarterial radioembolization (TARE) for liver metastases of neuroendocrine
tumors (NET): a feasibility study
por: Katharina Ingenerf, Maria, et al.
Publicado: (2021) -
Treatment Assessment of pNET and NELM after Everolimus by Quantitative MRI Parameters
por: Ingenerf, Maria, et al.
Publicado: (2022) -
Transarterial Radioembolization (TARE) Agents beyond (90)Y-Microspheres
por: Bouvry, C., et al.
Publicado: (2018) -
Clinical Results of Transarterial Radioembolization (TARE) with Holmium-166 Microspheres in the Multidisciplinary Oncologic Treatment of Patients with Primary and Secondary Liver Cancer
por: Drescher, Robert, et al.
Publicado: (2023) -
Transarterial Radioembolization (TARE) with
(131)
Iodine-Lipiodol for Unresectable Primary Hepatocellular Carcinoma: Experience from a Tertiary Care Center in India
por: Patel, Aakash, et al.
Publicado: (2021)